SGLT2 inhibition could potentially impact inflammation in acute myocardial infarction

Affiliations

¹ Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
² Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
³ Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

Comment

Harald Sourij et al. Eur Heart J. 2023.

. 2023 Oct 12;44(38):3931.

doi: 10.1093/eurheartj/ehad404.

¹ Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
² Clinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
³ Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.

No abstract available

Comment on

Empagliflozin in acute myocardial infarction: the EMMY trial.
von Lewinski D, Kolesnik E, Tripolt NJ, Pferschy PN, Benedikt M, Wallner M, Alber H, Berger R, Lichtenauer M, Saely CH, Moertl D, Auersperg P, Reiter C, Rieder T, Siller-Matula JM, Gager GM, Hasun M, Weidinger F, Pieber TR, Zechner PM, Herrmann M, Zirlik A, Holman RR, Oulhaj A, Sourij H. von Lewinski D, et al. Eur Heart J. 2022 Nov 1;43(41):4421-4432. doi: 10.1093/eurheartj/ehac494. Eur Heart J. 2022. PMID: 36036746 Free PMC article. Clinical Trial.
Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?
Trimaille A, Marchandot B, Morel O. Trimaille A, et al. Eur Heart J. 2023 Oct 12;44(38):3929-3930. doi: 10.1093/eurheartj/ehad257. Eur Heart J. 2023. PMID: 37350191 No abstract available.